Pamela R. Tessier
Hartford Hospital(US)
Publications by Year
Research Areas
Antibiotics Pharmacokinetics and Efficacy, Pneumonia and Respiratory Infections, Antibiotic Resistance in Bacteria, Antimicrobial Resistance in Staphylococcus, Cancer therapeutics and mechanisms
Most-Cited Works
- → Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Stucture−Activity Relationships(2008)222 cited
- → Pharmacodynamic Comparisons of Levofloxacin, Ciprofloxacin, and Ampicillin against Streptococcus pneumoniae in an In Vitro Model of Infection(1999)217 cited
- → Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin(1996)171 cited
- → Identifying Exposure Targets for Treatment of Staphylococcal Pneumonia with Ceftobiprole(2009)76 cited
- → Pharmacodynamic Assessment of Clarithromycin in a Murine Model of Pneumococcal Pneumonia(2002)75 cited
- → Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps(2006)68 cited
- → In Vivo Comparison of CXA-101 (FR264205) with and without Tazobactam versus Piperacillin-Tazobactam Using Human Simulated Exposures against Phenotypically Diverse Gram-Negative Organisms(2011)55 cited
- → Comparative In Vivo Efficacies of Epithelial Lining Fluid Exposures of Tedizolid, Linezolid, and Vancomycin for Methicillin-Resistant Staphylococcus aureus in a Mouse Pneumonia Model(2012)54 cited
- → Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis(1999)53 cited
- → Pharmacodynamic Assessment of Cefprozil against Streptococcus pneumoniae : Implications for Breakpoint Determinations(2000)46 cited